Newsroom

SAO PAULO--(BUSINESS WIRE)--Suzano (B3: SUZB3 / NYSE: SUZ), 's werelds grootste pulpproducent, maakt zijn resultaten bekend voor het derde kwartaal van 2026 (3Q26). Hierin is voor het eerst ook Arbex meegenomen, de joint venture tussen Suzano en Kimberly-Clark die in juli van dit jaar is opgericht. Vooral dankzij de consolidatie van de bijdrage van Arbex rapporteerde Suzano een netto-omzet van BRL 16,5 miljard, een stijging van 36% ten opzichte van dezelfde periode vorig jaar en een nieuw kwart...

ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (“Algoma”) (TSX:ALC) is pleased to announce that, in connection with its previously announced offering (the “Public Offering”) of $70,000,000 aggregate principal amount of 6.20% convertible unsecured subordinated debentures (the “Debentures”), Algoma has issued an additional $10,500,000 aggregate principal amount of Debentures pursuant to the full exercise of the over-allotment option (the “Over-Allotment Option”) granted to t...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 05.11.2026 SDVI.LN IE000YVOQ2A3   40,361.00 USD   1,151,166.36   28.522  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 05.11.2026 SDVY.LN IE0001R850E1 15,354,007.00 USD 387,203,904.85   25.218  ...

SAO PAULO--(BUSINESS WIRE)--Suzano (B3: SUZB3 / NYSE: SUZ), der weltweit größte Zellstoffhersteller, gibt seine Ergebnisse für das dritte Quartal 2026 (3Q26) bekannt, in denen erstmals auch Arbex berücksichtigt ist, das im Juli dieses Jahres gegründete Joint Venture zwischen Suzano und Kimberly-Clark. Vor allem aufgrund der Einbeziehung des Beitrags von Arbex verzeichnete Suzano einen Nettoumsatz von 16,5 Milliarden BRL, was einem Anstieg von 36 % gegenüber dem Vorjahreszeitraum entspricht und...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of an AI model for tumor and immune biology, announced today that it will present new data demonstrating the application of its biologically grounded AI in non-oncology indications at the American College of Rheumatology (ACR) Convergence 2026. ACR Convergence 2026, the world's premier rheumatology event, will be held November 6–11 at the Orange County Convention Center in Orlando, Florida. BostonGene combines multimodal profiling with biol...

RALEIGH, N.C.--(BUSINESS WIRE)--Vontier Declares Regular Dividend...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 05.11.2026 FTGS.LN IE000YZLMXT9   25,002.00 USD    575,133.11   23.003  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 05.11.2026 GFEB.LN IE000X8M8M80  650,002.00 USD  25,730,393.72   39.585  ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced that management will participate at the BMO Financials Conference on November 9 in Boca Raton, FL. The Company looks forward to discussing the details of its performance momentum, market opportunity, and business model with investors. About QuinStreet QuinStreet, Inc. (Nasdaq: QNST) is a leader in pe...